Novartis failed to persuade a U.S. appeals court on Wednesday to halt MSN Pharmaceuticals' proposed generic of Novartis' ...

Comparison measures of lung function and improved categorization of cardiovascular disease (CVD) risk were among the key ...

The U.S. Court of Appeals has reportedly ruled against Novartis (NVS) in its bid to prevent the U.S. launch of a generic ...

Novartis Pharmaceuticals Canada Inc. (Novartis) is pleased to announce the three recipients of its inaugural Health Equity ...

HSBC analyst Rajesh Kumar downgraded Novartis (NVS) to Reduce from Hold with a price target of CHF 82, down from CHF 95. The firm calls the ...

Fmr LLC grew its position in shares of Novartis AG (NYSE:NVS – Free Report) by 5.5% during the 3rd quarter, Holdings ...

Switzerland-based Novartis has one of the strongest and broadest portfolios of varied drugs that has enabled it to maintain its dominant position as a top pharma company over the years. It continues ...

Monte Rosa Therapeutics stock surged after a recent partnership with Novartis, despite limited clinical results. Can the ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

In my talks on innovation and simplification, I pose a simple question to my audiences: "How many of you wish you had more ...

The U.S. Food and Drug Administration has approved Merus NV's therapy that targets a particular gene, expanding treatment ...

The Centers for Medicare & Medicaid Services said on Wednesday it had entered into agreements with Vertex Pharmaceuticals and ...